<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu X</submitter><funding>NIGMS NIH HHS</funding><pagination>2082-93</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3777423</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(14)</volume><pubmed_abstract>The serine hydrolases constitute a large class of enzymes that play important roles in physiology. There is great interest in the development of potent and selective pharmacological inhibitors of these proteins. Traditional active-site inhibitors often have limited selectivity within this superfamily and are tedious and expensive to discover. Using the serine hydrolase RBBP9 as a model target, we designed a rapid and relatively inexpensive route to highly selective peptoid-based inhibitors that can be activated by visible light. This technology provides rapid access to photo-activated tool compounds capable of selectively blocking the function of particular serine hydrolases.</pubmed_abstract><journal>Chembiochem : a European journal of chemical biology</journal><pubmed_title>Rapid development of a potent photo-triggered inhibitor of the serine hydrolase RBBP9.</pubmed_title><pmcid>PMC3777423</pmcid><funding_grant_id>R01 GM090294</funding_grant_id><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Cravatt BF</pubmed_authors><pubmed_authors>Bachovchin DA</pubmed_authors><pubmed_authors>Kodadek TJ</pubmed_authors><pubmed_authors>Speers AE</pubmed_authors><pubmed_authors>Dix M</pubmed_authors><pubmed_authors>Zuhl AM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Rapid development of a potent photo-triggered inhibitor of the serine hydrolase RBBP9.</name><description>The serine hydrolases constitute a large class of enzymes that play important roles in physiology. There is great interest in the development of potent and selective pharmacological inhibitors of these proteins. Traditional active-site inhibitors often have limited selectivity within this superfamily and are tedious and expensive to discover. Using the serine hydrolase RBBP9 as a model target, we designed a rapid and relatively inexpensive route to highly selective peptoid-based inhibitors that can be activated by visible light. This technology provides rapid access to photo-activated tool compounds capable of selectively blocking the function of particular serine hydrolases.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Sep</publication><modification>2025-04-25T23:05:28.439Z</modification><creation>2019-03-27T01:16:13Z</creation></dates><accession>S-EPMC3777423</accession><cross_references><pubmed>22907802</pubmed><doi>10.1002/cbic.201200445</doi></cross_references></HashMap>